Grossman William
Known title: Interim Chief Medical OfficerCIK: 0001730229
Grossman William's purchase track record
Grossman William has no open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 9/22/2026 | ENGN | $10K | pending | pending | — |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| ENGN | ▲ Buy | Open Market | 5,102 | $10K | 9/22/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
enGene to Host KOL Webinar on Oct 15, 2026
enGene announced it will host a KOL webinar on Oct 15, 2026. The event will bring together key opinion leaders to discuss the company's therapeutic pipeline and clinical progress. The webinar could provide new insights for stakeholders and may influence market perception. The company remains in a lower part of its 52‑week range.
enGene to Host KOL Webinar on Oct 15, 2026. enGene announced it will host a KOL webinar on Oct 15, 2026. The event will bring together key opinion leaders to discuss the company's therapeutic pipeline and clinical progress. The webinar could provide new insights for stakeholders and may influence market perception. The company remains in a lower part of its 52‑week range.